Drug intelligence / Profile preview

umbelliferone

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Umbelliferone is a naturally occurring **coumarin derivative**, chemically known as **7-hydroxycoumarin**. It is found in many plants, especially those in the Umbelliferae and Rutaceae families. As a plant secondary metabolite, **umbelliferone displays a broad range of biological activities** and is used in research, cosmetics, and potentially as a therapeutic agent. It is known for its **antioxidant, anti-inflammatory, antimicrobial, antidiabetic, antitumor, and neuroprotective** properties[3][5][7]. Mechanistically, umbelliferone acts as a **potent inhibitor of type 3 17β-hydroxysteroid dehydrogenase**, impacting steroid metabolism[1], and **inhibits oxidative stress, inflammation, and apoptosis** in biological systems[7]. It also has uses in industry, including as a UV filter in sunscreens, fluorescent probe, optical brightener, and dye laser component[1][5]. Umbelliferone is not approved as a pharmaceutical drug but is widely studied for its therapeutic potential in diseases like diabetes, cancer, neurodegenerative disorders, and inflammatory diseases[3][7].

Other names
7-hydroxycoumarinhydrangin7-hydroxy-2H-chromen-2-oneskimmetineombelliférone7-hydroxy-2H-1-benzopyran-2-one
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)EGFR (Epidermal growth factor receptor)SFK (SRC family kinases)HSD17B3 (17-beta-hydroxysteroid dehydrogenase type 3)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)

Beyond the preview

Go deeper on umbelliferone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbelliferone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call